volume 189 pages 9-15

The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup

Karoliina Aro 1
Annukka Pasanen 2
Ralf Butzow 3
Mikko Loukovaara 4
Publication typeJournal Article
Publication date2024-10-01
scimago Q1
wos Q1
SJR1.881
CiteScore8.0
Impact factor4.1
ISSN00908258, 10956859
Abstract
To assess the risk stratification of clinicopathologically and molecularly classified endometrial cancer based on estrogen receptor (ER) and L1 cell adhesion molecule (L1CAM) expression.
Found 
Found 

Top-30

Journals

1
2
3
4
5
Gynecologic Oncology
5 publications, 31.25%
International Journal of Gynecological Cancer
2 publications, 12.5%
European Journal of Obstetrics, Gynecology and Reproductive Biology
2 publications, 12.5%
The Lancet Oncology
2 publications, 12.5%
Surgical and Experimental Pathology
1 publication, 6.25%
International Journal of Gynecological Pathology
1 publication, 6.25%
European Journal of Cancer
1 publication, 6.25%
Diagnostics
1 publication, 6.25%
American Journal of Obstetrics and Gynecology
1 publication, 6.25%
1
2
3
4
5

Publishers

2
4
6
8
10
12
14
Elsevier
13 publications, 81.25%
Springer Nature
1 publication, 6.25%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 6.25%
MDPI
1 publication, 6.25%
2
4
6
8
10
12
14
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
16
Share
Cite this
GOST |
Cite this
GOST Copy
Aro K. et al. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup // Gynecologic Oncology. 2024. Vol. 189. pp. 9-15.
GOST all authors (up to 50) Copy
Aro K., Pasanen A., Butzow R., Loukovaara M. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup // Gynecologic Oncology. 2024. Vol. 189. pp. 9-15.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ygyno.2024.06.016
UR - https://linkinghub.elsevier.com/retrieve/pii/S0090825824003317
TI - The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup
T2 - Gynecologic Oncology
AU - Aro, Karoliina
AU - Pasanen, Annukka
AU - Butzow, Ralf
AU - Loukovaara, Mikko
PY - 2024
DA - 2024/10/01
PB - Elsevier
SP - 9-15
VL - 189
PMID - 38972089
SN - 0090-8258
SN - 1095-6859
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Aro,
author = {Karoliina Aro and Annukka Pasanen and Ralf Butzow and Mikko Loukovaara},
title = {The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup},
journal = {Gynecologic Oncology},
year = {2024},
volume = {189},
publisher = {Elsevier},
month = {oct},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0090825824003317},
pages = {9--15},
doi = {10.1016/j.ygyno.2024.06.016}
}